Rakesh Popat (@drrakeshpopat) 's Twitter Profile
Rakesh Popat

@drrakeshpopat

Haematologist @uclh, Associate Professor @ucl. Cancer Lead NIHR UCLH Clinical Research Facility. Chair UK Myeloma Research Alliance. All views are my own.

ID: 1202400046760841218

linkhttps://www.uclh.nhs.uk/our-services/find-consultant/dr-rakesh-popat calendar_today05-12-2019 01:31:37

684 Tweet

1,1K Takipçi

496 Takip Edilen

Rakesh Popat (@drrakeshpopat) 's Twitter Profile Photo
Rakesh Popat
@drrakeshpopat

2 months ago

Great news that we now have Teclistamab, another BCMA bispecific antibody available as well as Elranatamab for myeloma patients. But still more work to do to widen access to Pomalidomide exposed patients.